Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009

Background Distant recurrence in women with oestrogen receptor-positive early breast cancer persists at a constant rate for more than 20 years after diagnosis, with little equivalent data for oestrogen receptor-negative breast cancer.